Xenon Pharmaceuticals XENE
NASDAQ XENE
$42.10 +0.71 (+1.72%)
At close: Nov 11, 2026 · 4:00 PM EST

Xenon Pharmaceuticals (XENE) Change in Accrued Expenses (2013 - 2026)

Updated

Xenon Pharmaceuticals (XENE) reported Change in Accrued Expenses of $5.72 million for Q2 2026, up 557.8% from $869,000 a year earlier.

Analysis

Xenon Pharmaceuticals (XENE) Change in Accrued Expenses (2013 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Xenon Pharmaceuticals' Change in Accrued Expenses came in at $12.34 million, up 732.7% year-over-year; for FY2025, it was $5.51 million, down 35.4% from FY2024.

  • Change in Accrued Expenses has a five-year compound annual growth rate of 22.2% (FY2020 to FY2025).
  • By year, Change in Accrued Expenses came in at $8.53 million in FY2024 (+117.0%), $3.93 million in FY2023 (-51.2%), $8.06 million in FY2022 (+171.4%) and $2.97 million in FY2021 (+46.9%).
  • The Q2 2026 figure ranks as the highest quarterly Change in Accrued Expenses since Q4 2024.
  • Year over year, Change in Accrued Expenses gained in two of the last four quarters, with growth averaging 146.9%.
  • The high point for year-over-year Change in Accrued Expenses in five years was Q2 2026 (growth of 557.8%); the low point was Q2 2025 (a decline of 90.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$1.8 million (Q1 2026), $3.19 million (Q4 2025) and $5.23 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Xenon Pharmaceuticals 4.07 Bn 542.89 Mn - 499,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 499,000.00
Jun 30, 2026 5.72 Mn
Mar 31, 2026 -1.80 Mn
Dec 31, 2025 3.19 Mn
Sep 30, 2025 5.23 Mn
Jun 30, 2025 869,000.00
Mar 31, 2025 -3.78 Mn
Dec 31, 2024 6.18 Mn
Sep 30, 2024 -1.79 Mn
Jun 30, 2024 9.15 Mn
Mar 31, 2024 -5.02 Mn
Dec 31, 2023 2.30 Mn
Sep 30, 2023 -3.36 Mn
Jun 30, 2023 5.58 Mn
Mar 31, 2023 -594,000.00
Dec 31, 2022 6.02 Mn
Sep 30, 2022 2.06 Mn
Jun 30, 2022 5.79 Mn
Mar 31, 2022 -5.80 Mn
Dec 31, 2021 3.76 Mn
API Access

Xenon Pharmaceuticals Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=XENE&period=max&api_key=YOUR_API_KEY